Allegheny Financial Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,698
Closed -$224K 213
2023
Q4
$224K Buy
+1,698
New +$224K 0.07% 194